(RI) Pernod Ricard S.A. - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000120693
Whiskey, Vodka, Gin, Rum, Champagne
Dividends
| Dividend Yield | 5.98% |
| Yield on Cost 5y | 3.51% |
| Yield CAGR 5y | 15.29% |
| Payout Consistency | 92.4% |
| Payout Ratio | 72.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.5% |
| Value at Risk 5%th | 44.2% |
| Relative Tail Risk | -8.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.97 |
| Alpha | -25.73 |
| CAGR/Max DD | -0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.544 |
| Beta | 0.110 |
| Beta Downside | 0.225 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.52% |
| Mean DD | 32.73% |
| Median DD | 35.96% |
Description: RI Pernod Ricard S.A. October 16, 2025
Pernod Ricard S.A. (ticker RI) is a Paris-based global producer of wines and spirits, offering a portfolio that spans premium whiskey, vodka, gin, rum, liqueurs, champagne, tequila, mezcal and aperitifs-including flagship brands such as Absolut, Chivas, Jameson, Glenlivet, Martell, and Havana Club-as well as a growing line of zero-alcohol beverages like Beefeater 0% and Ceder’s.
In FY 2023 the group generated €10.5 billion in revenue, with an adjusted EBITDA margin of roughly 22% and free cash flow of €1.5 billion, while maintaining net-debt to EBITDA around 2.0×. Key economic drivers include the ongoing premium-pricing tailwind in mature markets, accelerating demand for higher-margin spirits in Asia-Pacific (especially China and India), and a modest but fast-growing non-alcoholic segment that now contributes over 3% of total sales.
For a deeper dive into Pernod Ricard’s valuation metrics and scenario analysis, the ValueRay platform offers a granular, data-driven view worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.11b TTM) > 0 and > 6% of Revenue (6% = 1.20b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 0.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.43% (prev 54.86%; Δ -25.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 1.84b <= Net Income 2.11b (YES >=105%, WARN >=100%) |
| Net Debt (10.76b) to EBITDA (5.02b) ratio: 2.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (252.1m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 59.44% (prev 59.93%; Δ -0.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.64% (prev 29.63%; Δ 23.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.50 (EBITDA TTM 5.02b / Interest Expense TTM 973.5m) >= 6 (WARN >= 3) |
Altman Z'' 4.21
| (A) 0.16 = (Total Current Assets 12.36b - Total Current Liabilities 6.45b) / Total Assets 37.08b |
| (B) 0.32 = Retained Earnings (Balance) 11.77b / Total Assets 37.08b |
| (C) 0.11 = EBIT TTM 4.38b / Avg Total Assets 38.13b |
| (D) 1.29 = Book Value of Equity 26.98b / Total Liabilities 20.85b |
| Total Rating: 4.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.52
| 1. Piotroski 5.50pt |
| 2. FCF Yield 3.57% |
| 3. FCF Margin 5.43% |
| 4. Debt/Equity 0.83 |
| 5. Debt/Ebitda 2.14 |
| 6. ROIC - WACC (= 7.20)% |
| 7. RoE 13.23% |
| 8. Rev. Trend -7.69% |
| 9. EPS Trend 29.37% |
What is the price of RI shares?
As of December 02, 2025, the stock is trading at EUR 78.66 with a total of 540,285 shares traded.
Over the past week, the price has changed by +0.36%, over one month by -3.93%, over three months by -17.93% and over the past year by -21.55%.
Over the past week, the price has changed by +0.36%, over one month by -3.93%, over three months by -17.93% and over the past year by -21.55%.
Is RI a buy, sell or hold?
Pernod Ricard S.A. has no consensus analysts rating.
What are the forecasts/targets for the RI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 104.7 | 33.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 72.4 | -8% |
RI Fundamental Data Overview November 27, 2025
Market Cap USD = 22.95b (19.79b EUR * 1.1599 EUR.USD)
Market Cap EUR = 19.79b (19.79b EUR * 1.0 EUR.EUR)
P/E Trailing = 12.1891
P/E Forward = 12.5471
P/S = 1.8054
P/B = 1.2967
P/EG = 1.6308
Beta = 0.362
Revenue TTM = 20.07b EUR
EBIT TTM = 4.38b EUR
EBITDA TTM = 5.02b EUR
Long Term Debt = 10.44b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.81b EUR (from shortTermDebt, last quarter)
Debt = 12.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.76b EUR (from netDebt column, last quarter)
Enterprise Value = 30.55b EUR (19.79b + Debt 12.59b - CCE 1.83b)
Interest Coverage Ratio = 4.50 (Ebit TTM 4.38b / Interest Expense TTM 973.5m)
FCF Yield = 3.57% (FCF TTM 1.09b / Enterprise Value 30.55b)
FCF Margin = 5.43% (FCF TTM 1.09b / Revenue TTM 20.07b)
Net Margin = 10.49% (Net Income TTM 2.11b / Revenue TTM 20.07b)
Gross Margin = 59.44% ((Revenue TTM 20.07b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Gross Margin QoQ = 57.35% (prev 61.42%)
Tobins Q-Ratio = 0.82 (Enterprise Value 30.55b / Total Assets 37.08b)
Interest Expense / Debt = 1.83% (Interest Expense 231.0m / Debt 12.59b)
Taxrate = 23.38% (141.0m / 603.0m)
NOPAT = 3.36b (EBIT 4.38b * (1 - 23.38%))
Current Ratio = 1.92 (Total Current Assets 12.36b / Total Current Liabilities 6.45b)
Debt / Equity = 0.83 (Debt 12.59b / totalStockholderEquity, last quarter 15.21b)
Debt / EBITDA = 2.14 (Net Debt 10.76b / EBITDA 5.02b)
Debt / FCF = 9.86 (Net Debt 10.76b / FCF TTM 1.09b)
Total Stockholder Equity = 15.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.68% (Net Income 2.11b / Total Assets 37.08b)
RoE = 13.23% (Net Income TTM 2.11b / Total Stockholder Equity 15.92b)
RoCE = 16.62% (EBIT 4.38b / Capital Employed (Equity 15.92b + L.T.Debt 10.44b))
RoIC = 11.67% (NOPAT 3.36b / Invested Capital 28.76b)
WACC = 4.47% (E(19.79b)/V(32.37b) * Re(6.42%) + D(12.59b)/V(32.37b) * Rd(1.83%) * (1-Tc(0.23)))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈963.8m ; Y1≈1.19b ; Y5≈2.03b
Fair Price DCF = 137.1 (DCF Value 34.50b / Shares Outstanding 251.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 29.37 | EPS CAGR: 156.3% | SUE: -0.38 | # QB: 0
Revenue Correlation: -7.69 | Revenue CAGR: 3.65% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=6.20 | Chg30d=-0.294 | Revisions Net=-12 | Growth EPS=-14.6% | Growth Revenue=-9.0%
EPS next Year (2027-06-30): EPS=6.45 | Chg30d=-0.314 | Revisions Net=-13 | Growth EPS=+4.1% | Growth Revenue=+1.5%
Market Cap EUR = 19.79b (19.79b EUR * 1.0 EUR.EUR)
P/E Trailing = 12.1891
P/E Forward = 12.5471
P/S = 1.8054
P/B = 1.2967
P/EG = 1.6308
Beta = 0.362
Revenue TTM = 20.07b EUR
EBIT TTM = 4.38b EUR
EBITDA TTM = 5.02b EUR
Long Term Debt = 10.44b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.81b EUR (from shortTermDebt, last quarter)
Debt = 12.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.76b EUR (from netDebt column, last quarter)
Enterprise Value = 30.55b EUR (19.79b + Debt 12.59b - CCE 1.83b)
Interest Coverage Ratio = 4.50 (Ebit TTM 4.38b / Interest Expense TTM 973.5m)
FCF Yield = 3.57% (FCF TTM 1.09b / Enterprise Value 30.55b)
FCF Margin = 5.43% (FCF TTM 1.09b / Revenue TTM 20.07b)
Net Margin = 10.49% (Net Income TTM 2.11b / Revenue TTM 20.07b)
Gross Margin = 59.44% ((Revenue TTM 20.07b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Gross Margin QoQ = 57.35% (prev 61.42%)
Tobins Q-Ratio = 0.82 (Enterprise Value 30.55b / Total Assets 37.08b)
Interest Expense / Debt = 1.83% (Interest Expense 231.0m / Debt 12.59b)
Taxrate = 23.38% (141.0m / 603.0m)
NOPAT = 3.36b (EBIT 4.38b * (1 - 23.38%))
Current Ratio = 1.92 (Total Current Assets 12.36b / Total Current Liabilities 6.45b)
Debt / Equity = 0.83 (Debt 12.59b / totalStockholderEquity, last quarter 15.21b)
Debt / EBITDA = 2.14 (Net Debt 10.76b / EBITDA 5.02b)
Debt / FCF = 9.86 (Net Debt 10.76b / FCF TTM 1.09b)
Total Stockholder Equity = 15.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.68% (Net Income 2.11b / Total Assets 37.08b)
RoE = 13.23% (Net Income TTM 2.11b / Total Stockholder Equity 15.92b)
RoCE = 16.62% (EBIT 4.38b / Capital Employed (Equity 15.92b + L.T.Debt 10.44b))
RoIC = 11.67% (NOPAT 3.36b / Invested Capital 28.76b)
WACC = 4.47% (E(19.79b)/V(32.37b) * Re(6.42%) + D(12.59b)/V(32.37b) * Rd(1.83%) * (1-Tc(0.23)))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈963.8m ; Y1≈1.19b ; Y5≈2.03b
Fair Price DCF = 137.1 (DCF Value 34.50b / Shares Outstanding 251.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 29.37 | EPS CAGR: 156.3% | SUE: -0.38 | # QB: 0
Revenue Correlation: -7.69 | Revenue CAGR: 3.65% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=6.20 | Chg30d=-0.294 | Revisions Net=-12 | Growth EPS=-14.6% | Growth Revenue=-9.0%
EPS next Year (2027-06-30): EPS=6.45 | Chg30d=-0.314 | Revisions Net=-13 | Growth EPS=+4.1% | Growth Revenue=+1.5%